A research team from Iran investigated the accuracy of T2*-weighted magnetic resonance imaging (MRI T2*) in the evaluation of iron overload in beta-thalassemia major patients. The study showed that MRI T2* is a non-invasive, safe and reliable method for detecting iron load in patients with iron overload.
Iron overload is a common and serious problem in thalassemic major patients. As iron accumulation is toxic in the body’s tissues, accurate estimation of iron stores is of great importance in these patients to prevent iron overload by an appropriate iron chelating therapy. Liver biopsy is the gold standard for evaluating iron stores but it is an invasive method which is not easily repeatable in patients. Introduction of other more applicable methods seems to be necessary.
A research article published on January 28, 2011 in the World Journal of Gastroenterology addresses this question. The authors reported their experience of using T2*-weighted magnetic resonance imaging (MRI T2*) for determining iron overload in beta-thalassemic patients in Iran. They compared liver MRI T2* results in thalassemic patients with their liver biopsy results to determine if it is possible to substitute MRI T2* to assess iron overload in these patients.
The results indicated that the serum ferritin level is not a reliable method for estimating the level of iron overload in thalassemic patients. MRI T2* is a more accurate and non-invasive method which they recommend for measurement of iron load in these patients.
More information: Zamani F, Razmjou S, Akhlaghpoor S, Eslami SM, Azarkeivan A, Amiri A. T2* magnetic resonance imaging of the liver in thalassemic patients in Iran. World J Gastroenterol 2011;17(4): 522-525. http://www.wjgnet. … 7/i4/522.htm
The Kurdistan Thalassemia Care Center awarded those figures including Iraq’s First Lady Hero Talabani who sincerely contributed to provide aid and donation to the patients suffering from Thalassemia in Kurdistan region for 2010.
The awards were given in a ceremony held Thursday at Sulaimani office of the Kurdistan Thalassemia Care Center.
New Delhi: It did not matter that she could not understand English or could hardly pronounce ‘cord blood’, Krishna Devi Agarwal was only determined to end the suffering of her 8-year-old granddaughter, suffering from thalassemia since birth.
A resident of Patna in Bihar, the 60-year-old crisscrossed the country and visited countless hospitals during the last seven years until she learnt about stem cell therapy using cord blood which finally relieved Harshita from undergoing regular blood transfusions.
Harshita, a student of Delhi Public School in Patna, underwent a cord blood stem cell transplant last year in a hospital here and till date she has not undergone blood transfusion, a must for thalassemia patients.
“Her grandmother has been very influential in her treatment. She left no stone unturned to get her grand-child get relieved of the disease,” said Mrinalini Chaturvedi, medical director of Cryobanks International India, a private cord blood stem cells banking company that helped save Harshita’s life.
“I never read a newspaper but started going through them looking for some treatment opportunity for my grand daughter. And from one such newspaper I came to know that there is a relief in stem cell. I am thankful to ‘code bulaad (cord blood) kiyaro bank’ for the new lease of life they gave to my child,” she said.
Harshita is the first successful case of treatment of thalassemia child with cord blood stem cell of Cryobanks International India.
Harshita’s parents had stored their new-born son Yuvraj’s cord blood with them which was finally transplanted last year.
“She (Krishna) was confident that she would get Harshita relieved of the disease. She would accompany her to the hospital for blood transfusion. She would strictly follow the doctor’s instructions. She would be present before the doctor whichever day and time he would ask her to be there for Harshita’s treatment. She would voluntarily make an effort to know more about the disease and opportunities for treatment,” said Satya Narayan Agarwal, Harshita’s grandfather.
Army Hospital Research and Referral has also successfully treated many such thalassemic patients with help from bone marrow stem cells. Another private cord blood bank, Life Cell International, has helped in such treatment.
Thalassemia is a genetic blood disorder where the child has defective red blood cells and has to take repeated blood transfusion to survive and maintain hemoglobin levels.
Survival of such people is jeopardised by complications of the organ damage and sever anaemia. They have to take repeated medications to prevent accumulation of iron in the body. According to the ICMR, till date there are over one lakh thalassemic people in the country.